Your browser doesn't support javascript.
loading
A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline.
Liu, Xiaohui; Zheng, Weimin; Wang, Wansheng; Shen, Huali; Liu, Linxiao; Lou, Wenhui; Wang, Xiaolin; Yang, Pengyuan.
Affiliation
  • Liu X; Department of Chemistry, Fudan University, Shanghai 200433, China.
  • Zheng W; The Fifth People's Hospital of Shanghai, Fudan University, Shanghai 200240, China.
  • Wang W; Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
  • Shen H; Department of Chemistry, Fudan University, Shanghai 200433, China.
  • Liu L; Department of Interventional Radiology, First Affiliated Hospital, Soochow University, Suzhou 215006, China.
  • Lou W; Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
  • Wang X; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Yang P; Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Br J Cancer ; 118(6): e15, 2018 03 20.
Article in En | MEDLINE | ID: mdl-29438371
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Br J Cancer Year: 2018 Document type: Article Affiliation country: China Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Br J Cancer Year: 2018 Document type: Article Affiliation country: China Country of publication: United kingdom